Cargando…

Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway

OBJECTIVE: Myocardial ischemia/reperfusion (MI/R) injury is a major cause of cardiac tissue damage, with high disability and death rates. Although both dexmedetomidine (Dex) and propofol (PPF) have been indicated to alleviate MI/R injury in rat models, the effects of the combined use of these two dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ke, Ma, Yinhong, Xie, Chunmei, He, Lixian, Zhao, Haoxing, Dai, Zheng, Wang, Xiaoqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682120/
https://www.ncbi.nlm.nih.gov/pubmed/38034796
http://dx.doi.org/10.1016/j.heliyon.2023.e22054
_version_ 1785150909993451520
author Yang, Ke
Ma, Yinhong
Xie, Chunmei
He, Lixian
Zhao, Haoxing
Dai, Zheng
Wang, Xiaoqi
author_facet Yang, Ke
Ma, Yinhong
Xie, Chunmei
He, Lixian
Zhao, Haoxing
Dai, Zheng
Wang, Xiaoqi
author_sort Yang, Ke
collection PubMed
description OBJECTIVE: Myocardial ischemia/reperfusion (MI/R) injury is a major cause of cardiac tissue damage, with high disability and death rates. Although both dexmedetomidine (Dex) and propofol (PPF) have been indicated to alleviate MI/R injury in rat models, the effects of the combined use of these two drugs remain unclear. This study aimed to investigate the combined effects of Dex and PPF against MI/R injury and related mechanisms. METHODS: A rat model of MI/R injury was established and used to explore the combined effects of Dex and PPF on MI/R injury. Hematoxylin-eosin (HE) and Masson staining were used for histopathological evaluation. 2,3,5-triphenyltetrazolium chloride (TTC), echocardiography, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining were used to determine myocardial infarction size, cardiac function, and apoptosis, respectively. Enzyme-linked immunosorbent assay (ELISA) was performed to assess myocardial function and oxidative stress (OS). Autophagy was observed through transmission electron microscopy. Moreover, western blotting was conducted to detect autophagy markers and the AMPK pathway. RESULTS: The combination of Dex and PPF alleviated histopathological injury, reduced myocardial infarction, and rescued cardiac dysfunction in MI/R rats. Furthermore, Dex combined with PPF decreased the levels of MDA and ROS and increased the SOD level in MI/R rats. Besides, Dex combined with PPF inhibited myocardial apoptosis in MI/R rats. After combined treatment with Dex and PPF, the number of autophagosomes, expression levels of Beclin-1 and LC3II/LC3I were elevated, while the expression levels of p62 were reduced in MI/R rats. The combined use of Dex and PPF activated the AMPK pathway in MI/R rats. Compound C (an AMPK inhibitor) could abolish the combined effects of Dex and PPF on alleviating myocardial injury and enhancing autophagy in MI/R rats. CONCLUSION: The combination of Dex and PPF attenuated MI/R injury in rats, which may be associated with the activation of the AMPK signaling pathway.
format Online
Article
Text
id pubmed-10682120
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-106821202023-11-30 Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway Yang, Ke Ma, Yinhong Xie, Chunmei He, Lixian Zhao, Haoxing Dai, Zheng Wang, Xiaoqi Heliyon Research Article OBJECTIVE: Myocardial ischemia/reperfusion (MI/R) injury is a major cause of cardiac tissue damage, with high disability and death rates. Although both dexmedetomidine (Dex) and propofol (PPF) have been indicated to alleviate MI/R injury in rat models, the effects of the combined use of these two drugs remain unclear. This study aimed to investigate the combined effects of Dex and PPF against MI/R injury and related mechanisms. METHODS: A rat model of MI/R injury was established and used to explore the combined effects of Dex and PPF on MI/R injury. Hematoxylin-eosin (HE) and Masson staining were used for histopathological evaluation. 2,3,5-triphenyltetrazolium chloride (TTC), echocardiography, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) staining were used to determine myocardial infarction size, cardiac function, and apoptosis, respectively. Enzyme-linked immunosorbent assay (ELISA) was performed to assess myocardial function and oxidative stress (OS). Autophagy was observed through transmission electron microscopy. Moreover, western blotting was conducted to detect autophagy markers and the AMPK pathway. RESULTS: The combination of Dex and PPF alleviated histopathological injury, reduced myocardial infarction, and rescued cardiac dysfunction in MI/R rats. Furthermore, Dex combined with PPF decreased the levels of MDA and ROS and increased the SOD level in MI/R rats. Besides, Dex combined with PPF inhibited myocardial apoptosis in MI/R rats. After combined treatment with Dex and PPF, the number of autophagosomes, expression levels of Beclin-1 and LC3II/LC3I were elevated, while the expression levels of p62 were reduced in MI/R rats. The combined use of Dex and PPF activated the AMPK pathway in MI/R rats. Compound C (an AMPK inhibitor) could abolish the combined effects of Dex and PPF on alleviating myocardial injury and enhancing autophagy in MI/R rats. CONCLUSION: The combination of Dex and PPF attenuated MI/R injury in rats, which may be associated with the activation of the AMPK signaling pathway. Elsevier 2023-11-04 /pmc/articles/PMC10682120/ /pubmed/38034796 http://dx.doi.org/10.1016/j.heliyon.2023.e22054 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Yang, Ke
Ma, Yinhong
Xie, Chunmei
He, Lixian
Zhao, Haoxing
Dai, Zheng
Wang, Xiaoqi
Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
title Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
title_full Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
title_fullStr Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
title_full_unstemmed Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
title_short Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway
title_sort dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the ampk signaling pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682120/
https://www.ncbi.nlm.nih.gov/pubmed/38034796
http://dx.doi.org/10.1016/j.heliyon.2023.e22054
work_keys_str_mv AT yangke dexmedetomidinecombinedwithpropofolattenuatesmyocardialischemiareperfusioninjurybyactivatingtheampksignalingpathway
AT mayinhong dexmedetomidinecombinedwithpropofolattenuatesmyocardialischemiareperfusioninjurybyactivatingtheampksignalingpathway
AT xiechunmei dexmedetomidinecombinedwithpropofolattenuatesmyocardialischemiareperfusioninjurybyactivatingtheampksignalingpathway
AT helixian dexmedetomidinecombinedwithpropofolattenuatesmyocardialischemiareperfusioninjurybyactivatingtheampksignalingpathway
AT zhaohaoxing dexmedetomidinecombinedwithpropofolattenuatesmyocardialischemiareperfusioninjurybyactivatingtheampksignalingpathway
AT daizheng dexmedetomidinecombinedwithpropofolattenuatesmyocardialischemiareperfusioninjurybyactivatingtheampksignalingpathway
AT wangxiaoqi dexmedetomidinecombinedwithpropofolattenuatesmyocardialischemiareperfusioninjurybyactivatingtheampksignalingpathway